Vaxcyte, Inc. - PCVX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$10.07B
QoQ value delta ($000)
-$2.134M (-0.02%)
Implied price effect (QoQ)
-0.0%
Shares
Total shares
173,178,095
QoQ shares delta
-29,728 (-0.02%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PCVX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 71 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 1,212,179 20,852,907 0.05%
Jupiter Topco LLC 1,044,355 17,965,847 0.43%
T. Rowe Price Investment Management, Inc. 709,620 12,207,450 0.47%
BlackRock, Inc. 701,520 12,068,129 0.01%
RA CAPITAL MANAGEMENT, L.P. 667,018 11,474,599 5.8%
WELLINGTON MANAGEMENT GROUP LLP 407,000 7,001,565 0.07%
VANGUARD PORTFOLIO MANAGEMENT LLC 383,283 6,593,551 0.02%
VANGUARD CAPITAL MANAGEMENT LLC 369,048 6,348,679 0.01%
STATE STREET CORP 311,090 5,351,698 0.01%
Deep Track Capital, LP 249,959 4,300,000 3.64%
GEODE CAPITAL MANAGEMENT, LLC 201,130 3,459,363 0.01%
PRICE T ROWE ASSOCIATES INC /MD/ 173,751 2,988,999 0.02%
Kynam Capital Management, LP 169,875 2,922,335 9.39%
WESTFIELD CAPITAL MANAGEMENT CO LP 143,722 2,472,428 0.47%
Caligan Partners LP 127,225 2,188,636 5.99%
Paradigm Biocapital Advisors LP 123,692 2,127,852 2.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 120,823 2,078,506 0.01%
Bellevue Group AG 114,628 1,971,935 2.41%
D. E. Shaw & Co., Inc. 110,555 1,901,872 0.05%
Caption Management, LLC 98,640 1,696,900 0.46%
MAVERICK CAPITAL LTD 93,777 1,613,242 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 85,149 1,464,812 0.01%
Pivotal bioVenture Partners Investment Advisor LLC 82,862 1,425,470 26.92%
EVENTIDE ASSET MANAGEMENT, LLC 80,229 1,380,219 1.07%
GOLDMAN SACHS GROUP INC 79,978 1,375,860 0.01%